Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study

OBJECTIVE: To determine the differences between recommendations by the National Comprehensive Cancer Network (NCNN) guidelines and Food and Drug Administration approvals of anticancer drugs, and the evidence cited by the NCCN to justify recommendations where differences exist. DESIGN: Retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Jeffrey, Marquart, John, Ruby, Julia, Lammers, Austin, Mailankody, Sham, Kaestner, Victoria, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838851/
https://www.ncbi.nlm.nih.gov/pubmed/29514787
http://dx.doi.org/10.1136/bmj.k668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838851/
https://www.ncbi.nlm.nih.gov/pubmed/29514787
http://dx.doi.org/10.1136/bmj.k668

Ejemplares similares